Molluscum contagiosum

molluscumUntil now, the best treatment was to do nothing, but could a new drug, MolluDab, offer a cure? This DTB article reviews the evidence (DTB 2014;52(10):110).

MolluDab is 5% potassium hydroxide solution applied twice daily with a dabber. An inflammatory response should occur after 4-6d with lesions disappearing over the next 1-5w. It is available over the counter (OTC) and on prescription (except in Scotland). The RRP is £24.30 for 2ml! The main side effect is stinging/burning, with redness, itching, pain, ulceration, crusting and hyperpigmentation also reported.

The two main trials were tiny (<30 patients). The DTB review concluded there was no convincing effect and do not recommend prescribing it.

So, are there any other options? Well, unfortunately not. A Cochrane review showed no benefits from available treatments (Cochrane 2009, CD004767). Looks like we should just continue to leave alone then!

Aimee Lettis

Aimee Lettis from the GP Update team gives us short, sharp nuggets of clinical information for sessional GPs. The GP Update team run one-day courses, bringing GPs up to date with all the latest evidence and guidelines.

Use the NASGP CPD templates to record your reflections.

Latest posts by Aimee Lettis (see all)

No Comments Yet.

Leave your comments